IRWD - JMP starts Ironwood at market outperform cites potential of GLP-2 drug
2023-09-28 12:52:41 ET
More on Ironwood Pharmaceuticals
- Ironwood: Pipeline Progresses As FDA Approves LINZESS
- Ironwood Pharmaceuticals, Inc. (IRWD) Q2 2023 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on Ironwood Pharmaceuticals
- Historical earnings data for Ironwood Pharmaceuticals
- Financial information for Ironwood Pharmaceuticals
For further details see:
JMP starts Ironwood at market outperform, cites potential of GLP-2 drug